In the second installment of a 3-part series on long-acting injectables related to various infections, Caitlin Soto, PharmD, BCIDP, provides insights on using rezafungin for invasive candidiasis.
Caitlin Soto, PharmD, BCIDP
Advertisement
Soto is a clinical pharmacy specialist, Antimicrobial Stewardship & Infectious Diseases, at The Johns Hopkins Hospital in Baltimore, MD.
Articles by Caitlin Soto, PharmD, BCIDP
Advertisement
Latest Updated Articles
A Long-Acting Injectable for the Treatment of Candida spp InfectionsPublished: September 25th 2024 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Clinical Takeaways From ViiV’s PASO DOBLE and CLARITY Studies
2
Phage and Antibiotic Combination Therapy for Biofilm-Associated Bacterial Infections
3
Streamlining IV-to-Oral Transitions in Pneumonia Care: Duration, Tailoring, and Post-Discharge Considerations
4
WHO Calls for Global Action on Growing AMR
5
